Syed Hissar

Dr. Syed Hissar

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2011 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
NTNirupma Trehanpati
Nirupma Trehanpati
SSSukriti Sukriti
Sukriti Sukriti
RGRobert Geffers
Robert Geffers
SHSyed Hissar
Syed Hissar
PRPeggy Riese
Peggy Riese
SSShiv Kumar Sarin
Shiv Kumar Sarin

1 July 2020 in Indian Journal of Tuberculosis
Verified
Journal Article
Closed access
PGPrathiksha Giridharan
Prathiksha Giridharan
ESElilarasi Selladurai
Elilarasi Selladurai
SBSarath Balaji
Sarath Balaji
SPSnegha Karunakaran Pramila
Snegha Karunakaran Pramila
AVArunagirinathan V
Arunagirinathan V
BDBella Devaleenal Daniel
Bella Devaleenal Daniel

23 July 2024 in Viruses
Verified
Journal Article
Open access
PDF file
AVAgalya Vanamudhu
Agalya Vanamudhu
RARenuka Devi Arumugam
Renuka Devi Arumugam
APArul Nancy Pandiarajan
Arul Nancy Pandiarajan
NSNandhini Selvaraj
Nandhini Selvaraj
KAKadar Moideen Abbas
Kadar Moideen Abbas
NKNathella Pavan Kumar
Nathella Pavan Kumar
A natural infection or a vaccination can initially prime the immune system to form immunological memory. The immunity engendered by vaccination against COVID-19 versus natural infection with SARS-CoV-2 has not been well studied in the Indian population. In this study, we compared the immunity conferred by COVID-19 vaccines to naturally acquired immunity to SARS-CoV-2 in a South Indian population. We examined binding and neutralizing antibody (NAb) levels against the ancestral and variant lineages and assessed the ex vivo cellular parameters of memory T cells, memory B cells, and monocytes and finally measured the circulating cytokine response. COVID-19 vaccination stimulates heightened levels of IgG antibodies against the original strain of SARS-CoV-2, as well as increased binding to the spike protein and neutralizing antibody levels. This enhanced response extends to variant lineages such as B.1.617.2 (Delta, India), B.1.1.529 (Omicron, India), B.1.351 (Beta, South Africa), and B.1.1.7 (Alpha, UK). COVID-19 vaccination differs from SARS-CoV-2 infection by having increased frequencies of classical memory B cells, activated memory B and plasma cells, CD4/CD8 T cells of effector memory, effector cells, stem cell-like memory T cells, and classical and intermediate monocytes and diminished frequencies of CD4/CD8 T cells of central memory and non-classical monocytes in vaccinated individuals in comparison to those with natural infection. Thus, COVID-19 vaccination is characterized by enhanced humoral responses and robust activation of innate and memory T cell responses in comparison to natural infection in a South Indian population.

30 April 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
NKNathella Pavan Kumar
Nathella Pavan Kumar
RMRajamariyam M
Rajamariyam M
ANArul Nancy
Arul Nancy
BKBubby S. Kumar
Bubby S. Kumar
JMJanakiram M
Janakiram M
SBSubash Babu
Subash Babu
Introduction: Tuberculosis (TB) remains the primary cause of death among individuals infected with HIV, increasing the risk of contracting TB by up to 26 times. This co-infection complicates the diagnosis and treatment of TB, ultimately affecting outcomes adversely. Acute-phase proteins (APPs), markers of inflammation, are significantly elevated during infections and serve as critical indicators of inflammation resulting from infectious diseases.Methods: In this prospective study, HIV-positive individuals at antiretroviral therapy (ART) clinics were screened for latent tuberculosis infection (LTBI) before starting isoniazid (INH) prophylaxis. Initially, 101 patients were enrolled, with 71 completing a six-month follow-up on INH prophylaxis. LTBI was diagnosed using QuantiFERON-TB Gold plus, categorizing participants as HIV-positive with LTBI (n=30) and HIV-positive without LTBI (n=71).Results: Plasma levels of alpha-2-macroglobulin (A2M), C-reactive protein (CRP), serum amyloid P (SAP), haptoglobin, ferritin, soluble transferrin receptor (sTFR), apotransferrin, hepcidin, and S100A8/A9 were assessed using multiplex and quantikine assays.At baseline, levels of A2M, CRP, SAP, ferritin, hepcidin, and S100A9 were significantly elevated in HIV-positive patients with LTBI compared to those without LTBI (A2M, p=0.005; CRP, p<0.001; SAP, p=0.0006; ferritin, p<0.001; hepcidin, p=0.001; S100A9, p=0.001). Following six months of INH prophylaxis, significant reductions in these markers were observed in both groups, suggesting a reduction in inflammation.Discussion: Our findings indicate that a baseline profile of APPs can effectively reflect the inflammatory status of HIV patients with LTBI. These inflammatory markers tend to decrease following effective INH treatment, underscoring their potential utility in monitoring disease progression and treatment response in this vulnerable population.

27 May 2025 in Diseases
Verified
Journal Article
Open access
PDF file
NKNathella Pavan Kumar
Nathella Pavan Kumar
SHSyed Hissar
Syed Hissar
APArul Nancy Pandiarajan
Arul Nancy Pandiarajan
KTKannan Thiruvengadam
Kannan Thiruvengadam
VBVelayuthum V. Banurekha
Velayuthum V. Banurekha
SBSubash Babu
Subash Babu
Diagnosing tuberculosis (TB) in children presents significant challenges, necessitating the identification of reliable biomarkers for accurate diagnosis. In this study, we investigated plasma matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) as potential diagnostic markers. A prospective case–control study involved 167 children classified into confirmed TB, unconfirmed TB, and unlikely TB control groups. Plasma levels of MMPs (MMP 1, 2, 3, 7, 8, 9, 12, and 13) and TIMPs (TIMP 1, 2, 3, and 4) were measured using multiplex assays. Elevated baseline levels of MMP-1, MMP-2, MMP-7, MMP-9, TIMP-1, TIMP-2, TIMP-3, and TIMP-4 were observed in active TB cases compared to unlikely TB controls. Receiver operating characteristics (ROC) analysis identified MMP-1, MMP-2, MMP-9, and TIMP-1 as potential biomarkers with over 80% sensitivity and specificity. A three-MMP signature (MMP-1, MMP-2, and MMP-9) demonstrated 100% sensitivity and specificity. The findings suggest that a baseline MMP signature could serve as an accurate biomarker for diagnosing pediatric TB, enabling early intervention and effective management.

28 February 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
NKNathella Pavan Kumar
Nathella Pavan Kumar
SMSaravanan Munisankar
Saravanan Munisankar
BDBindu Dasan
Bindu Dasan
ANArul Nancy
Arul Nancy
KTKannan Thiruvengadam
Kannan Thiruvengadam
SBSubash Babu
Subash Babu
Background: This study investigates how Strongyloides stercoralis (Ss) infection impacts pulmonary tuberculosis (PTB) treatment outcomes, disease severity, and bacterial burdens in PTB patients with Ss coinfection. Methods: We used chest x-rays and sputum smear grades to assess lung conditions and bacterial loads in 483 PTB patients. Ss infection was confirmed by seropositivity, and cytokine and profibrotic factor levels were analyzed using multiplex enzyme-linked immunosorbent assay. Treatment outcomes were categorized as favorable (cure without recurrence) or unfavorable (treatment failure or TB recurrence) during treatment or within 12 months postcure. Results: PTB patients coinfected with Ss had significantly higher bacterial loads, increased risk of bilateral lung lesions, and greater likelihood of cavitary disease compared with those without Ss infection. The coinfected individuals exhibit significantly increased levels of cytokines (interleukin [IL]-4, IL-5, IL-13, interferon [IFN]-α, and IFN-β) and profibrotic factors (vascular endothelial growth factor, epidermal growth factor [EGF], fibroblast growth factor 2 [FGF-2], and PDGF-AB/BB [platelet-derived growth factor]) and significantly diminished levels of cytokines (IFN-γ and IL-2). Conclusions: This study underscores the exacerbating impact of Ss coinfection on PTB severity and treatment outcomes, emphasizing the need for integrated management strategies for affected patients.